Philogen S.p.a.
Clinical trials sponsored by Philogen S.p.a., explained in plain language.
-
New injection before surgery aims to stop Melanoma's return
Disease control Recruiting nowThis study is testing if a new drug called Daromun, injected directly into melanoma tumors before surgery, can help patients stay cancer-free longer. It will compare patients who get the injection plus surgery and standard follow-up care against those who get only surgery and fol…
Phase: PHASE3 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Apr 02, 2026 01:11 UTC
-
New cancer drug trial seeks patients Who've exhausted other options
Disease control Recruiting nowThis early-stage study is testing the safety and early effectiveness of an experimental drug called IL12-L19L19 in people with advanced solid tumors that have spread. The trial is for patients whose cancer has continued to grow despite receiving standard immunotherapy. Researcher…
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
First human test of targeted 'Tumor Glow' therapy for tough cancers
Disease control Recruiting nowThis early-stage study is testing a new radioactive drug, given alone or with an immune-boosting drug, for people with advanced cancers that have a specific marker called FAP. The main goal is to find a safe dose and see how well the body handles the treatment. It is for patients…
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New shot tested for stubborn arthritis pain
Disease control Recruiting nowThis early-stage study is testing the safety of a new drug called F8IL10, which is injected directly into an inflamed joint. Researchers want to find the highest dose that is safe and well-tolerated in adults with rheumatoid arthritis who still have flare-ups despite their regula…
Phase: PHASE1 • Sponsor: Philogen S.p.A. • Aim: Disease control
Last updated Mar 12, 2026 13:51 UTC